Andre R. Brunoni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andre R. Brunoni has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Adriano Augusto Domingos Neto
Universidade de São Paulo
1 shared publication - Alisson Rafael Oliveira Lima
Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil
1 shared publication Beatriz A. Cavendish
Service of Interdisciplinary Neuromodulation, Department, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil
1 shared publication- Beatriz Araújo Cavendish
Department of Basic Psychological Processes, Institute of Psychology, University of Brasília, Brasília 70.910-900, Brazil
1 shared publication Bianca Silva Pinto
Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil
1 shared publicationClaudia Kimie Suemoto
Division of Geriatrics, University of Sao Paulo Medical School, Sao Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (5) , 2537-2546
Dose or time? Comparing early prediction of intermittent theta-burst stimulation response across accelerated and daily protocols for depression
Objective: To compare early response prediction across accelerated and standard intermittent theta-burst stimulation (iTBS) protocols for major depressive disorder, examining whether predictive performance differs when assessments are matched by cumulative pulse exposure versus calendar time. Methods: Pooled analysis of two prospective iTBS trials conducted at Instituto de Psiquiatria, Hospital das Clínicas, Universidade de São Paulo: the open-label BRAEN-MAP trial (once-daily; N = 65; 20 sessions over 4 weeks) and the active arm of the triple-blind, sham-controlled randomized TTT trial (accelerated; N = 50; 45 sessions over 3 weeks). Assessments were matched by cumulative pulses (18,000 pulses), calendar time (Weeks 1 and 2), or session count (15 sessions). Early improvement was defined as ≥ 20% HDRS-17 reduction. Positive predictive values (PPV) and negative predictive values (NPV) were compared using bootstrap resampling. Results: Response rates did not differ between trials (BRAEN-MAP: 55.4%; TTT: 54.0%; p = 0.95). For response prediction, PPV ranged from 66.7% to 75.0% across protocol-timepoint combinations, with no significant differences between protocols at pulse-matched (66.7% vs. 68.9%, p = 0.84), time-matched, or session-matched (66.7% vs. 68.8%, p = 0.86) comparisons (all bootstrap p > 0.43). NPV for non-response prediction ranged from 69.0% to 82.4%, also without significant between-protocol differences. Trajectory analyses demonstrated that early improvers maintained steeper improvement through endpoint. Conclusion: Early symptom improvement predicts iTBS response consistently across accelerated and standard protocols regardless of whether assessments are matched by cumulative pulses, calendar time, or number of sessions. These preliminary findings support early response assessment as a protocol-independent clinical tool, though the accuracy levels observed (PPV 67–75%) are insufficient to justify treatment discontinuation and may be most useful within adaptive, measurement-based care frameworks.
- 1 June 2026
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (5) , 2537-2546
Open AccessDose or time? Comparing early prediction of intermittent theta-burst stimulation response across accelerated and daily protocols for depression
Objective: To compare early response prediction across accelerated and standard intermittent theta-burst stimulation (iTBS) protocols for major depressive disorder, examining whether predictive performance differs when assessments are matched by cumulative pulse exposure versus calendar time. Methods: Pooled analysis of two prospective iTBS trials conducted at Instituto de Psiquiatria, Hospital das Clínicas, Universidade de São Paulo: the open-label BRAEN-MAP trial (once-daily; N = 65; 20 sessions over 4 weeks) and the active arm of the triple-blind, sham-controlled randomized TTT trial (accelerated; N = 50; 45 sessions over 3 weeks). Assessments were matched by cumulative pulses (18,000 pulses), calendar time (Weeks 1 and 2), or session count (15 sessions). Early improvement was defined as ≥ 20% HDRS-17 reduction. Positive predictive values (PPV) and negative predictive values (NPV) were compared using bootstrap resampling. Results: Response rates did not differ between trials (BRAEN-MAP: 55.4%; TTT: 54.0%; p = 0.95). For response prediction, PPV ranged from 66.7% to 75.0% across protocol-timepoint combinations, with no significant differences between protocols at pulse-matched (66.7% vs. 68.9%, p = 0.84), time-matched, or session-matched (66.7% vs. 68.8%, p = 0.86) comparisons (all bootstrap p > 0.43). NPV for non-response prediction ranged from 69.0% to 82.4%, also without significant between-protocol differences. Trajectory analyses demonstrated that early improvers maintained steeper improvement through endpoint. Conclusion: Early symptom improvement predicts iTBS response consistently across accelerated and standard protocols regardless of whether assessments are matched by cumulative pulses, calendar time, or number of sessions. These preliminary findings support early response assessment as a protocol-independent clinical tool, though the accuracy levels observed (PPV 67–75%) are insufficient to justify treatment discontinuation and may be most useful within adaptive, measurement-based care frameworks.
- Open Access
- 21 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Chronicity moderates the impact of severity on central executive-default mode network functional interactions in depression
Neuroimaging has revealed that major depression is underpinned by dysfunctional brain networks, with symptom variability stemming from altered interactions within and between brain regions. While the effect of depression severity is well-studied, the effect of depression duration (chronicity) is relatively neglected, despite its clinical significance. This study examined how severity, chronicity, and their interaction affect brain network connectivity and grey matter volume. Forty-six patients (31 females, mean age 40.5) were assessed using whole-brain network modeling and voxel-based morphometry (VBM). Severity was measured via the Hamilton Depression Rating Scale, and chronicity was defined as an episode lasting over 24 months. The key finding was that chronicity moderated the impact of severity on functional connectivity between the Central Executive Network (CEN) and the precuneus (part of the Default Mode Network, DMN). Chronic versus non-chronic patients showed opposite patterns. Non-chronic patients showed stronger CEN-Default Mode Precuneus connectivity at low severity and weaker at high severity; chronic patients showed the reverse. This study reveals a novel impact of chronicity on CEN-DMN interactions, a neglected moderator of brain-symptom severity correlations in depression.
- 21 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessChronicity moderates the impact of severity on central executive-default mode network functional interactions in depression
Neuroimaging has revealed that major depression is underpinned by dysfunctional brain networks, with symptom variability stemming from altered interactions within and between brain regions. While the effect of depression severity is well-studied, the effect of depression duration (chronicity) is relatively neglected, despite its clinical significance. This study examined how severity, chronicity, and their interaction affect brain network connectivity and grey matter volume. Forty-six patients (31 females, mean age 40.5) were assessed using whole-brain network modeling and voxel-based morphometry (VBM). Severity was measured via the Hamilton Depression Rating Scale, and chronicity was defined as an episode lasting over 24 months. The key finding was that chronicity moderated the impact of severity on functional connectivity between the Central Executive Network (CEN) and the precuneus (part of the Default Mode Network, DMN). Chronic versus non-chronic patients showed opposite patterns. Non-chronic patients showed stronger CEN-Default Mode Precuneus connectivity at low severity and weaker at high severity; chronic patients showed the reverse. This study reveals a novel impact of chronicity on CEN-DMN interactions, a neglected moderator of brain-symptom severity correlations in depression.
- Open Access
- 30 December 2025
- Published by Elsevier in Brain Stimulation
- Vol. 19 (1) , 103021
US FDA approves home-delivered tDCS for treating depression
- 30 December 2025
- Published by Elsevier in Brain Stimulation
- Vol. 19 (1) , 103021
Open AccessUS FDA approves home-delivered tDCS for treating depression
- Open Access
- 21 August 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (5) , 1608-1616
Transcranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial
- 21 August 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (5) , 1608-1616
Open AccessTranscranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial